Crimson Publishers Publish With Us Reprints e-Books Video articles


Modern Research in Dentistry

Is Dental Implant Placement Compatible in Patients Treated with Bisphosphonates? A Literature Review

Submission: July 03, 2019 Published: July 19, 2019

DOI: 10.31031/MRD.2019.04.000585

Volume4 Issue2


Background: Bisphosphonates (BP) are a group of drugs used in treatment and prevention of alterated turn-over of bone diseases. Since 2003, it is known That BP are able to develop osteonecrosis of the jaw (BRONJ: Bisphosphonate-Related Osteonecrosis of the Jaw) when they are associated to any surgical trauma, even dental implant therapy.

Materials and Methods: Comprehensive research of scientific articles from ten years ago to our days in Medline (Pubmed).

Results and Discussion: 1090 dental implants placed patients treated with BP and 3472 dental implants placed in healthy patients had successfully rates of 97.6% and 97.9%, respectively. Therefore, implant placement in patients in treatment with BP does not reduce implant success rates. Besides, BRONJ appears before with intravenous vs oral administration of BP.

Conclusion: Further well-designed long-term studies are necessary to evaluate correctly the relationship between BP and dental implants.

Keywords: Dental implant; Osteonecrosis; Bisphosphonate; Bisphosphonate-related osteonecrosis of the jaw

Abbreviations: BP: Bisphosphonates; BRONJ: Bisphosphonate Related Osteonecrosis of the Jaw; CTX: C Terminal Telopeptide, TCT; AAOMS: The American Association of Oral and Maxillofacial Surgeons

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137